Clinical Trials Directory

Trials / Sponsors / Kowa Company, Ltd.

Kowa Company, Ltd.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intoler
Hypercholesterolemia
Phase 32023-05-01
CompletedA Phase III Confirmatory Study of K-237
Covid19
Phase 32021-10-22
CompletedA Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C
Hyperlipidemia
Phase 32021-09-17
CompletedA Phase III Long Term Study of K-877 Extended Release Tablet
Dyslipidemias
Phase 32021-02-01
CompletedA Phase III Confirmatory Study of K-877 Extended Release Tablet
Dyslipidemias
Phase 32021-02-01
CompletedK-924 Phase III Confirmatory Study
Hypercholesterolemia
Phase 32020-04-02
CompletedK-924 Phase III Long Term Study
Hypercholesterolemia
Phase 32020-03-23
CompletedA Clinical Pharmacology Study of K-877 Controlled Release Tablet
Dyslipidemias
Phase 22019-09-13
CompletedA Study to Evaluate the Safety of K-755 in Healthy Volunteers
Healthy
Phase 12018-02-27
CompletedA Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease
Phase 22017-12-27
CompletedTofogliflozin GLP-1 Analogue Combination Trial
Type 2 Diabetes Mellitus
Phase 42015-08-01
CompletedStudy of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Hepatic Neoplasm Malignant Recurrent
Phase 32012-04-01